John Bondo Hansen
Mikael Thomsen
Niels Skjærbæk


Povl Krogsgaard-Larsen, Professor, Dr.Pharm 

Former chairman of the Carlsberg foundation and the Carlsberg Brewery. Former member of the Lundbeck foundation. Former chairman or Auriga. 


Jørgen Vestbo, Dr. Med. 

Professor of Respiratory Medicine. U. Manchester. 

Saher B. Shaker, MD. PhD  

Chief Physician, pulmonary medicine, Gentofte hospital. Denmark.


Uffe Holmskov, Dr. Med. 

Professor Odense, Denmark 


John Bondo Hansen, Founder, CEO

John Bondo Hansen is PhD in medicinal chemistry and has more 30 years experience in drug discovery. From 2002 to 2008 he served as vice president at Novo Nordisk. From 2007 to 2014 he has been board director of Aurigene Discovery Technologies (India) and from 2008 to 2010 he was founder and CSO of Sound Biotech. He is founder of Konticon Consulting in 2008. In 2010 he and Mikael Thomsen founded Contera Pharma that was acquired by Bukwang Pharma in 2014. He has published about 70 scientific papers and 50 patents and patent applications.

Mikael Thomsen, Founder, CSO

Mikael Thomsen is Ph.D. in Pharmacology & Toxicology, with more than 15 years of experience from FDA, Novartis and Novo Nordisk, and several European Biotechs of which he has co-founded Prosidion Ltd.  and Sound Biotech. In all these companies, he has managed all the activities necessary for taking a compound from late Discovery to Phase II/cPoC. Mikael is a strong advocate for accelerated drug development. He has since mid 2010 acted as CSO of Bridge BioResearch. He has authored or co-authored more than 50 publications and abstracts.


Niels Skjærbæk, COO

Niels Skjærbæk is Ph.D. in medicinal chemistry, with more than 15 years experience from pharma and biotech.